Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 110351-110400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03399799
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
279 participants
Started: Dec 16, 2017 · Completed: Mar 30, 2029
1 condition
1 sponsor
13 locations
NCT03281317
Vasoplegic Syndrome in Cardiac Surgery
N/A
Active, not recruiting
1,113 participants
Started: Dec 15, 2017 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT03408080
Open Pilot Trial of BHV-4157
PHASE3
Active, not recruiting
24 participants
Started: Dec 15, 2017 · Completed: Dec 15, 2024
6 conditions
1 sponsor
1 location
NCT03344731
Cognitive Abilities in Brain Damaged Patients
NA
Recruiting
100 participants
Started: Dec 15, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03321552
PROMISE International
NA
Active, not recruiting
35 participants
Started: Dec 15, 2017 · Completed: Dec 24, 2025
1 condition
1 sponsor
12 locations
NCT03360994
WATChmAN Virtual Testicular Cancer Clinic
NA
Active, not recruiting
144 participants
Started: Dec 15, 2017 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT03326791
Aspirin in Colorectal Cancer Liver Metastases
PHASE2/PHASE3
Active, not recruiting
466 participants
Started: Dec 15, 2017 · Completed: Jun 30, 2026
3 conditions
4 sponsors
14 locations
NCT03158090
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
N/A
Recruiting
1,965 participants
Started: Dec 15, 2017 · Completed: Jan 30, 2051
1 condition
1 sponsor
1 location
NCT03371212
A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA
PHASE4
Active, not recruiting
52 participants
Started: Dec 15, 2017 · Completed: Dec 1, 2026
1 condition
2 sponsors
1 location
NCT04926584
Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option
N/A
Recruiting
50 participants
Started: Dec 15, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04761068
Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts
N/A
Recruiting
1,000 participants
Started: Dec 15, 2017 · Completed: Mar 30, 2026
1 condition
1 sponsor
13 locations
NCT03635554
Translation and Clinical Implementation of a Test of Language and Short-term Memory in Aphasia
N/A
Enrolling by invitation
150 participants
Started: Dec 15, 2017 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT04098315
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.
N/A
Recruiting
300 participants
Started: Dec 14, 2017 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT03315026
Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis
PHASE2
Active, not recruiting
30 participants
Started: Dec 14, 2017 · Completed: Oct 31, 2025
2 conditions
2 sponsors
1 location
NCT03689842
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
NA
Recruiting
20 participants
Started: Dec 14, 2017 · Completed: Dec 14, 2034
1 condition
1 sponsor
1 location
NCT03033043
Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection
NA
Active, not recruiting
56 participants
Started: Dec 14, 2017 · Completed: Oct 31, 2026
1 condition
1 sponsor
21 locations
NCT03280511
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
PHASE2
Recruiting
60 participants
Started: Dec 14, 2017 · Completed: Mar 1, 2027
4 conditions
1 sponsor
1 location
NCT03432325
Neural Enabled Prosthesis for Upper Limb Amputees
NA
Recruiting
15 participants
Started: Dec 14, 2017 · Completed: Dec 31, 2025
3 conditions
3 sponsors
2 locations
NCT03374215
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
N/A
Recruiting
1,150 participants
Started: Dec 14, 2017 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT03320304
A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.
N/A
Recruiting
500 participants
Started: Dec 14, 2017 · Completed: Dec 1, 2028
1 condition
1 sponsor
18 locations
NCT03358979
Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
N/A
Recruiting
100 participants
Started: Dec 14, 2017 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT03181256
Early Detection of Lung Cancer
N/A
Active, not recruiting
45 participants
Started: Dec 14, 2017 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT03377387
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
PHASE1/PHASE2
Active, not recruiting
34 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
10 locations
NCT03212170
FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer
PHASE2
Active, not recruiting
20 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03274258
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
PHASE2
Active, not recruiting
10 participants
Started: Dec 13, 2017 · Completed: Jul 31, 2027
4 conditions
2 sponsors
1 location
NCT03386305
Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
PHASE2/PHASE3
Active, not recruiting
35 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2021
1 condition
2 sponsors
1 location
NCT03266783
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
PHASE4
Active, not recruiting
2,760 participants
Started: Dec 13, 2017 · Completed: Aug 31, 2025
1 condition
3 sponsors
19 locations
NCT03541057
Vienna Vascular Liver Disease Study
N/A
Recruiting
200 participants
Started: Dec 12, 2017 · Completed: Dec 31, 2024
7 conditions
1 sponsor
1 location
NCT03319628
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
PHASE1/PHASE2
Active, not recruiting
523 participants
Started: Dec 12, 2017 · Completed: Oct 31, 2024
2 conditions
1 sponsor
1 location
NCT03285412
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
PHASE2
Active, not recruiting
120 participants
Started: Dec 12, 2017 · Completed: Oct 31, 2026
1 condition
2 sponsors
3 locations
NCT03301506
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
PHASE3
Active, not recruiting
500 participants
Started: Dec 12, 2017 · Completed: Nov 30, 2028
1 condition
1 sponsor
108 locations
NCT03424018
An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
PHASE3
Active, not recruiting
119 participants
Started: Dec 12, 2017 · Completed: Jun 30, 2031
1 condition
1 sponsor
24 locations
NCT03199300
Investigating Cardiovascular Adverse Events Related to Cancer Treatment
N/A
Active, not recruiting
20 participants
Started: Dec 12, 2017 · Completed: Jan 31, 2027
3 conditions
1 sponsor
1 location
NCT03362060
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
PHASE1
Active, not recruiting
20 participants
Started: Dec 12, 2017 · Completed: Dec 30, 2027
2 conditions
2 sponsors
3 locations
NCT03384927
Effect of Treatment Dairy for Spasticity
N/A
Enrolling by invitation
96 participants
Started: Dec 11, 2017 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT03260400
Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals
NA
Recruiting
10 participants
Started: Dec 11, 2017 · Completed: May 5, 2029
2 conditions
2 sponsors
1 location
NCT03362294
Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS
PHASE2
Active, not recruiting
30 participants
Started: Dec 11, 2017 · Completed: Sep 30, 2026
1 condition
1 sponsor
7 locations
NCT03411317
Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling
N/A
Active, not recruiting
350 participants
Started: Dec 11, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03596086
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PHASE1/PHASE2
Recruiting
62 participants
Started: Dec 11, 2017 · Completed: Dec 30, 2025
2 conditions
3 sponsors
1 location
NCT03450603
Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease
N/A
Recruiting
200 participants
Started: Dec 10, 2017 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT03399253
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
PHASE2/PHASE3
Recruiting
120 participants
Started: Dec 10, 2017 · Completed: Dec 1, 2025
1 condition
1 sponsor
9 locations
NCT03266874
G7 BiSpherical Acetabular Shell PMCF Study
N/A
Active, not recruiting
160 participants
Started: Dec 10, 2017 · Completed: Dec 31, 2031
8 conditions
1 sponsor
5 locations
NCT04102566
Optimizing Pain Control in Transurethral Resection of the Prostate
PHASE4
Recruiting
50 participants
Started: Dec 8, 2017 · Completed: Dec 1, 2019
3 conditions
2 sponsors
1 location
NCT03376425
Transthoracic Shear-wave Ultrasound Elastography
N/A
Recruiting
2,000 participants
Started: Dec 8, 2017 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT03159702
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
PHASE2
Active, not recruiting
43 participants
Started: Dec 8, 2017 · Completed: Nov 15, 2025
2 conditions
1 sponsor
1 location
NCT03017131
Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE1
Active, not recruiting
9 participants
Started: Dec 8, 2017 · Completed: Mar 23, 2032
3 conditions
2 sponsors
1 location
NCT03363061
Patients on Antithrombotics for Colonoscopy
N/A
Recruiting
6,000 participants
Started: Dec 8, 2017 · Completed: Nov 30, 2028
2 conditions
2 sponsors
1 location
NCT03211416
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer
PHASE1/PHASE2
Active, not recruiting
37 participants
Started: Dec 7, 2017 · Completed: Dec 7, 2025
9 conditions
2 sponsors
2 locations
NCT03374267
Registry Platform Urologic Cancer
N/A
Recruiting
1,930 participants
Started: Dec 7, 2017 · Completed: Sep 30, 2028
2 conditions
1 sponsor
1 location
NCT02974621
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PHASE2
Active, not recruiting
70 participants
Started: Dec 7, 2017 · Completed: Jul 17, 2026
1 condition
1 sponsor
27 locations
Previous
1
More pages
2205
2206
2207
2208
2209
2210
2211
More pages
2369
Next